These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 2417350

  • 1. Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen--levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivator.
    Jespersen J, Kluft C.
    Thromb Haemost; 1985 Aug 30; 54(2):454-9. PubMed ID: 2417350
    [Abstract] [Full Text] [Related]

  • 2. The diurnal increase in euglobulin fibrinolytic activity in women using oral contraceptives and in normal women, and the generation of intrinsic fibrinolytic activity.
    Jespersen J.
    Thromb Haemost; 1986 Oct 21; 56(2):183-8. PubMed ID: 3101221
    [Abstract] [Full Text] [Related]

  • 3. Effects of two low-dose oral contraceptives on circulating components of the coagulation and fibrinolytic systems.
    Gevers Leuven JA, Kluft C, Bertina RM, Hessel LW.
    J Lab Clin Med; 1987 Jun 21; 109(6):631-6. PubMed ID: 3108429
    [Abstract] [Full Text] [Related]

  • 4. Sequential study of plasma euglobulin fibrinolytic activity during the normal menstrual cycle and in women on oral contraceptives low in estrogen.
    Jespersen J.
    Gynecol Obstet Invest; 1983 Jun 21; 15(5):266-74. PubMed ID: 6852646
    [Abstract] [Full Text] [Related]

  • 5. Plasminogen activators in dextran sulfate-activated euglobulin fractions: a molecular analysis of factor XII- and prekallikrein-dependent fibrinolysis.
    Hauert J, Nicoloso G, Schleuning WD, Bachmann F, Schapira M.
    Blood; 1989 Mar 21; 73(4):994-9. PubMed ID: 2465792
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid.
    Jespersen J, Petersen KR, Skouby SO.
    Am J Obstet Gynecol; 1990 Jul 21; 163(1 Pt 2):396-403. PubMed ID: 2196812
    [Abstract] [Full Text] [Related]

  • 8. Studies on plasma coagulation and fibrinolysis during oral contraception of various types with special reference to cold activation of factor VII.
    Gjonnaess H, Fagerhol MK.
    Scand J Haematol; 1974 Jul 21; 12(3):232-40. PubMed ID: 4831827
    [Abstract] [Full Text] [Related]

  • 9. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
    Quehenberger P, Kapiotis S, Pärtan C, Schneider B, Wenzel R, Gaiger A, Speiser W.
    Ann Hematol; 1993 Jul 21; 67(1):33-6. PubMed ID: 8392873
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of euglobulin methods for the study of blood fibrinolytic activity: results for patients with rheumatoid arthritis and in the postoperative period.
    Kluft C, Cooper P, Jie AF, Lowe GD, Forbes CD, Blamey SL, van de Putte LB.
    Haemostasis; 1985 Jul 21; 15(2):144-50. PubMed ID: 3874124
    [Abstract] [Full Text] [Related]

  • 11. [Blood coagulation and fibrinolysis in women receiving estrogen, gestagen and estrogen-gestagen-contraceptives (author's transl)].
    Lechner K, Hartmann E, Schneider WH, Spona J, Matt K.
    Klin Wochenschr; 1976 May 01; 54(9):431-8. PubMed ID: 1271696
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of tissue-type plasminogen activator in plasma of women using oral contraceptives and in normal women during a menstrual cycle.
    Jespersen J, Kluft C.
    Thromb Haemost; 1986 Jun 30; 55(3):388-9. PubMed ID: 3092396
    [Abstract] [Full Text] [Related]

  • 13. Acute effect of smoking on fibrinolysis: increase in the activity level of circulating extrinsic (tissue-type) plasminogen activator.
    Allen RA, Kluft C, Brommer EJ.
    Eur J Clin Invest; 1984 Oct 30; 14(5):354-61. PubMed ID: 6437833
    [Abstract] [Full Text] [Related]

  • 14. Effect on blood coagulation and fibrinolysis in women using norethisterone or a combination of ethinyloestradiol and quingestianol.
    Korsan-Bengtsen K, Larsson B.
    Gynecol Obstet Invest; 1978 Oct 30; 9(6):312-8. PubMed ID: 754993
    [Abstract] [Full Text] [Related]

  • 15. Factor XII-dependent fibrinolysis: a double function of plasma kallikrein and the occurrence of a previously undescribed factor XII- and kallikrein-dependent plasminogen proactivator.
    Kluft C, Trumpi-Kalshoven MM, Jie AF, Veldhuyzen-Stolk EC.
    Thromb Haemost; 1979 Jun 30; 41(4):756-73. PubMed ID: 483248
    [Abstract] [Full Text] [Related]

  • 16. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A, Ruusuvaara L.
    Thromb Haemost; 1988 Dec 22; 60(3):361-4. PubMed ID: 3149043
    [Abstract] [Full Text] [Related]

  • 17. Lipids and blood coagulation studies in women using steroidal hormones for contraception.
    Hashmi JA, Kazi AB, Kazi A, Ali N.
    J Pak Med Assoc (1951); 1972 Aug 22; 22(8):218-25. PubMed ID: 12305803
    [Abstract] [Full Text] [Related]

  • 18. No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids.
    Petersen KR, Kjems LL, Skouby SO, Andersen LF, Jespersen J.
    Metabolism; 1996 Jul 22; 45(7):833-7. PubMed ID: 8692017
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.